OncLiveNovel Immunotherapy Shows Early Efficacy in Uveal MelanomaOncLiveIMCgp100, a novel immune-based treatment, demonstrated a 1-year survival rate of 73% (95% CI, 46%-88%) for patients with heavily pretreated, advanced uveal melanoma, which is nearl… Continue reading
Investor’s Business DailyMomentum grows for hemophilia gene therapies | BioPharma DiveBioPharma DiveAn experimental gene therapy developed by BioMarin Pharmaceutical eliminated spontaneous bleeding and restored activity of a blood clotting protein to&n… Continue reading
TimeGazetteSynthetic Biology Market 2025 with Focus on Emerging Technologies, Global Trends, Competitive Landscape …Expert ConsultingSynthetic Biology Market – Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Compe… Continue reading
Business Wire (press release)T-Cell Immunotherapy Market Projected to Grow at an Annualized Rate of 86%, Predicts Roots AnalysisBusiness Wire (press release)Pemba Lahmo, the principal analyst, stated, “With two approved therapies and over 480 clinical… Continue reading
|
Trial Results Are Positive For Two Rare Disease Gene Therapies
Pharmaceutical Processing To date, 11 patients have been dosed with a single intravenous injection of the ABO-102 gene therapy for systemic delivery of a functional copy of the missing SGSH gene associated with onset and progression of the disease. The SGSH gene provides … Explore the latest developments in ATMPs at SMi’s Cell & Gene Therapy 2018EIN News (press release) |
FierceBiotech |
Spark hemophilia B gene therapy clears test en route to Pfizer …
FierceBiotech Spark Therapeutics has presented data on hemophilia B patients who received a version of its gene therapy manufactured using a modified process. Early data … Hunting a cure, Spark reports steady progress on hemophilia B …Endpoints News Spark’s gene therapy SPK-9001 shows treatment benefit in …Seeking Alpha Spark, Pfizer report progress on gene therapy for hemophiliaPhiladelphia Business Journal pharmaphorum –PMLiVE all 27 news articles » |
Phys.Org |
These CRISPR-modified crops don’t count as GMOs – Phys.org
Phys.Org To feed the burgeoning human population, it is vital that the world figures out ways to boost food production. These CRISPR-modified crops don’t count as GMOs – San Francisco …San Francisco Chronicle |